EYEG EyeGate Pharmaceuticals, Inc.

NASDAQ
$33.73

EyeGate Pharmaceuticals, Inc. (EYEG) Institutional Ownership

What the institutions did with EYEG last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to.

No institutional holdings on record for EYEG.